Is there a role for preference assessments in research on quality of life in oncology?

J. E. Till, H. J. Sutherland, E. M. Meslin

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

The development of ways to evaluate interventions that may have an impact on quality of life is a rapidly=developing area of research in clinical oncology, especially within the context of randomized controlled trials. We propose a role for assessments of preferences in such evaluations, including preference studies designed to assess attitudes toward the clinical acceptability of interventions, and preference trials designed to assess choice behaviour in relation to interventions. We suggest that such preference assessments represent a specific case of a more general issue: the need to develop an 'ethics of evidence', that is, standards for the creation, assessment and communication of evidence. We then outline a framework within which an 'ethics of evidence' might be developed, and suggest that the framework also may provide a useful model for the processes involved in the transfer of research results into clinical practice. As an illustration, we consider the problem of decision making in circumstances where the choice of therapy depends primarily on the patient's own preferences, as, for example, in the choice of mastectomy or breast-conserving treatment in early-stage breast cancer. The long-term goal is to develop criteria which might be used to foster shared rational decision making in such circumstances.

Original languageEnglish (US)
Pages (from-to)31-40
Number of pages10
JournalQuality of Life Research
Volume1
Issue number1
DOIs
StatePublished - Feb 1992
Externally publishedYes

Fingerprint

Ethics
Decision Making
Quality of Life
Choice Behavior
Medical Oncology
Patient Preference
Mastectomy
Research
Breast
Randomized Controlled Trials
Communication
Breast Neoplasms
Therapeutics

Keywords

  • Clinical trials
  • decision making
  • patient preferences
  • quality of life

ASJC Scopus subject areas

  • Nursing(all)
  • Rehabilitation

Cite this

Is there a role for preference assessments in research on quality of life in oncology? / Till, J. E.; Sutherland, H. J.; Meslin, E. M.

In: Quality of Life Research, Vol. 1, No. 1, 02.1992, p. 31-40.

Research output: Contribution to journalArticle

Till, J. E. ; Sutherland, H. J. ; Meslin, E. M. / Is there a role for preference assessments in research on quality of life in oncology?. In: Quality of Life Research. 1992 ; Vol. 1, No. 1. pp. 31-40.
@article{1972749089764ec18b0ee1590a87a7a1,
title = "Is there a role for preference assessments in research on quality of life in oncology?",
abstract = "The development of ways to evaluate interventions that may have an impact on quality of life is a rapidly=developing area of research in clinical oncology, especially within the context of randomized controlled trials. We propose a role for assessments of preferences in such evaluations, including preference studies designed to assess attitudes toward the clinical acceptability of interventions, and preference trials designed to assess choice behaviour in relation to interventions. We suggest that such preference assessments represent a specific case of a more general issue: the need to develop an 'ethics of evidence', that is, standards for the creation, assessment and communication of evidence. We then outline a framework within which an 'ethics of evidence' might be developed, and suggest that the framework also may provide a useful model for the processes involved in the transfer of research results into clinical practice. As an illustration, we consider the problem of decision making in circumstances where the choice of therapy depends primarily on the patient's own preferences, as, for example, in the choice of mastectomy or breast-conserving treatment in early-stage breast cancer. The long-term goal is to develop criteria which might be used to foster shared rational decision making in such circumstances.",
keywords = "Clinical trials, decision making, patient preferences, quality of life",
author = "Till, {J. E.} and Sutherland, {H. J.} and Meslin, {E. M.}",
year = "1992",
month = "2",
doi = "10.1007/BF00435433",
language = "English (US)",
volume = "1",
pages = "31--40",
journal = "Quality of Life Research",
issn = "0962-9343",
publisher = "Springer Netherlands",
number = "1",

}

TY - JOUR

T1 - Is there a role for preference assessments in research on quality of life in oncology?

AU - Till, J. E.

AU - Sutherland, H. J.

AU - Meslin, E. M.

PY - 1992/2

Y1 - 1992/2

N2 - The development of ways to evaluate interventions that may have an impact on quality of life is a rapidly=developing area of research in clinical oncology, especially within the context of randomized controlled trials. We propose a role for assessments of preferences in such evaluations, including preference studies designed to assess attitudes toward the clinical acceptability of interventions, and preference trials designed to assess choice behaviour in relation to interventions. We suggest that such preference assessments represent a specific case of a more general issue: the need to develop an 'ethics of evidence', that is, standards for the creation, assessment and communication of evidence. We then outline a framework within which an 'ethics of evidence' might be developed, and suggest that the framework also may provide a useful model for the processes involved in the transfer of research results into clinical practice. As an illustration, we consider the problem of decision making in circumstances where the choice of therapy depends primarily on the patient's own preferences, as, for example, in the choice of mastectomy or breast-conserving treatment in early-stage breast cancer. The long-term goal is to develop criteria which might be used to foster shared rational decision making in such circumstances.

AB - The development of ways to evaluate interventions that may have an impact on quality of life is a rapidly=developing area of research in clinical oncology, especially within the context of randomized controlled trials. We propose a role for assessments of preferences in such evaluations, including preference studies designed to assess attitudes toward the clinical acceptability of interventions, and preference trials designed to assess choice behaviour in relation to interventions. We suggest that such preference assessments represent a specific case of a more general issue: the need to develop an 'ethics of evidence', that is, standards for the creation, assessment and communication of evidence. We then outline a framework within which an 'ethics of evidence' might be developed, and suggest that the framework also may provide a useful model for the processes involved in the transfer of research results into clinical practice. As an illustration, we consider the problem of decision making in circumstances where the choice of therapy depends primarily on the patient's own preferences, as, for example, in the choice of mastectomy or breast-conserving treatment in early-stage breast cancer. The long-term goal is to develop criteria which might be used to foster shared rational decision making in such circumstances.

KW - Clinical trials

KW - decision making

KW - patient preferences

KW - quality of life

UR - http://www.scopus.com/inward/record.url?scp=0026596294&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026596294&partnerID=8YFLogxK

U2 - 10.1007/BF00435433

DO - 10.1007/BF00435433

M3 - Article

C2 - 1301113

AN - SCOPUS:0026596294

VL - 1

SP - 31

EP - 40

JO - Quality of Life Research

JF - Quality of Life Research

SN - 0962-9343

IS - 1

ER -